HKHarald Kotisch

Harald Kotisch

*This is an algorithmically generated author record based on publicly available information.

Harald Kotisch has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    PITHD1: An Endogenous Inhibitor of the 26S Proteasome During Cellular Dormancy

    by Sascha J. Amann, Ken Dong, Josef Roehsner, Dominik Krall, Irina Grishkovskaya, Harald Kotisch, Alexander Schleiffer, Elisabeth Roitinger, Andrea Pauli, Andreas Martin, et al.

    Cellular dormancy represents a state of regulated growth arrest essential for diverse biological processes, from reproduction to cancer progression. While mechanisms controlling protein synthesis in dormant cells have been identified, how cells regulate protein degradation during dormancy remains unclear. Using zebrafish oocytes, eggs and embryos as a model system, we discovered PITHD1 as an endogenous inhibitor of the 26S proteasome. Our high-resolution cryoEM structure reveals that PITHD1 simultaneously blocks three crucial functional sites on the 19S regulatory particle which are required for ubiquitin recognition, processing, and substrate translocation. This triple-lock mechanism effectively prevents protein degradation in dormant cells. Given PITHD1’s evolutionary conservation across species, this mechanism likely represents a general strategy for reversible proteasome regulation during cellular dormancy. Our findings establish a new paradigm for controlling proteostasis in quiescent states.


  • Open Access

    A multivalent adaptor mechanism drives the nuclear import of proteasomes

    by Hanna Leonie Brunner, Robert Wolfgang Kalis, Lorenz Grundmann, Zuzana Hodáková, Zuzana Koskova, Irina Grishkovskaya, Melanie de Almeida, Matthias Hinterndorfer, Simon Hoefflin, Florian Andersch, et al.

    Nuclear protein homeostasis, including the turnover of transcription factors, critically depends on nuclear proteasomes. After each cell division, proteasomes need to be re-imported into the newly formed nucleus in a highly dynamic process that requires the largely unstructured protein AKIRIN2. However, how AKIRIN2 orchestrates this process and, more generally, how large protein complexes are translocated into the nucleus remains poorly understood. Here, we have used an integrated approach combining protein-wide saturation mutagenesis screens, cryoEM, and biochemical reconstitution to characterize AKIRIN2 as a scaffold protein that coordinates the stepwise assembly of an importin cluster around the proteasome. Through surveying every possible single amino acid substitution in AKIRIN2 using FACS- and microscopy-based genetic screens, we establish a comprehensive map of functionally relevant residues and binding interfaces in structured and disordered protein regions. Integrating these results with cryoEM analysis reveals a wing helix in a disordered region of AKIRIN2 that plays a crucial role in stabilizing proteasome interactions. Upon primary binding, AKIRIN2 homodimers recruit the importin IPO9, which in turn facilitates the binding of a second AKIRIN2 homodimer that recruits additional importins. Together, this multivalent molecular assembly amplifies the number of nuclear localisation signals and, thereby, triggers efficient proteasome translocation into the nucleus. Inside the nucleus, RanGTP rapidly dissociates importins, and AKIRIN2 is degraded by the proteasome in a ubiquitin-independent manner. Beyond mechanistically resolving the nuclear import of proteasomes, we propose that multivalent adaptor proteins like AKIRIN2 orchestrate the import of other macromolecular complexes and thereby dynamically control the composition of the nuclear proteome.


  • Open Access

    Cryo‐EM structure of the chain‐elongating E3 ubiquitin ligase UBR5

    by Zuzana Hodáková, Irina Grishkovskaya, Hanna L Brunner, Derek L Bolhuis, Katarina Belačić, Alexander Schleiffer, Harald Kotisch, Nicholas G Brown, David Haselbach

    UBR5 is a nuclear E3 ligase that ubiquitinates a vast range of substrates for proteasomal degradation. This HECT domain-containing ubiquitin ligase has recently been identified as an important regulator of oncogenes, e.g., MYC, but little is known about its structure or mechanisms of substrate engagement and ubiquitination. Here, we present the cryo-EM structure of human UBR5, revealing an α-solenoid scaffold with numerous protein-protein interacting motifs, assembled into an antiparallel dimer that adopts further oligomeric states. Using cryo-EM processing tools, we observe the dynamic nature of the UBR5 catalytic domain, which we postulate is important for its enzymatic activity. We characterise the proteasomal nuclear import factor AKIRIN2 as an interacting protein and propose UBR5 as an efficient ubiquitin chain elongator. This preference for ubiquitinated substrates and several distinct domains for protein-protein interactions may explain how UBR5 is linked to several different signalling pathways and cancers. Together, our data expand on the limited knowledge of the structure and function of HECT E3 ligases.


  • Open Access

    Cryo-EM structure of the chain-elongating E3 ligase UBR5

    by Zuzana Hodáková, Irina Grishkovskaya, Hanna L. Brunner, Derek L. Bolhuis, Katarina Belačić, Alexander Schleiffer, Harald Kotisch, Nicholas G. Brown, David Haselbach

    UBR5 is a nuclear E3 ligase that ubiquitinates a vast range of substrates for proteasomal degradation. This HECT E3 ligase has recently been identified as an important regulator of oncogenes, e.g., MYC, but little is known about its structure or mechanisms of substrate engagement and ubiquitination. Here, we present the cryo-EM structure of the human UBR5, revealing a building block of an antiparallel dimer which can further assemble into larger oligomers. The large helical scaffold of the dimer is decorated with numerous protein-interacting motifs for substrate engagement. Using cryo-EM processing tools, we observe the dynamic nature of the domain movements of UBR5, which allows the catalytic HECT domain to reach engaged substrates. We characterise the proteasomal nuclear import factor AKIRIN2 as an interacting protein and propose UBR5 as an efficient ubiquitin chain elongator. This preference for ubiquitinated substrates permits UBR5 to function in several different signalling pathways and cancers. Together, our data expand on the limited knowledge of the structure and function of HECT E3s.